Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
作者： Sriram Balasubramanian , Norbert Purro , Tarak D. Mody , Joseph J. Buggy , David J. Loury
DOI:
关键词:
摘要: Dosing regimens, methods of treatment, controlled release formulations, and combination therapies that include bendamustine, or a pharmaceutically acceptable salt thereof an HDAC inhibitor, thereof, are described.
lens.org 参考文章(137)
Fried Josef, Acetals and ketals of 16, 17-dihydroxy steroids ,(1960)
Jane Pei-Fan Bai, Pulsatile drug delivery system ,(1997)
Multiparticulate Oral Drug Delivery CRC Press. ,(1994) , 10.1201/B14855
Isaac Ghebre-Sellassie, Pharmaceutical pelletization technology M. Dekker. ,(1989)
Jonathan A Ellman, Jin Mi Kim, Daniel Goldberg, Non-quinoline inhibitors of malaria parasites ,(2000)
John D. Kalvelage, Child resistant package assembly for dispensing pharmaceutical medications ,(1993)
Joseph J. Buggy, Sriram Balasubramanian, Methods for determining cancer resistance to histone deacetylase inhibitors ,(2008)
William S Allen, Robert H Lenhard, Bernstein Seymour, 16-alpha oxy-belta1, 4-pregnadienes ,(1956)
Martin Golebiewski, Bernd Hentsch, Pier Giuseppe Pelicci, Thorsten Heinzel, Saverio Minucci, Alexander B. Maurer, Oliver H. Krämer, Martin Göttlicher, Ping Zhu, The use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity ,(2003)
Chih-Ming Chen, Diltiazem controlled release formulation ,(1996)